Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 450-455

  Ou, Horng Yih ^a   Yang, Yi Ching ^a   Wu, Hung Tsung ^a   Wu, Jin Shang ^a   Lu, Feng Hwa ^a   Chang, Chih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FETUIN A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; ALPHA-2-HS-GLYCOPROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 80052544718     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04070.x     Document Type: Article

References (33)

1. Wild, S., Roglic, G., Green, A., et al. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053. (Pubitemid 38579764)
2. Yang, W., Lu, J., Weng, J., et al. (2010) Prevalence of diabetes among men and women in China. The New England Journal of Medicine, 362, 1090-1101.
3. Nathan, D.M., Davidson, M.B., DeFronzo, R.A., et al. (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care, 30, 753-759. (Pubitemid 46354366)
4. Faerch, K., Borch-Johnsen, K., Holst, J.J., et al. (2009) Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia, 52, 1714-1723.
5. Rasouli, N., &, Kern, P.A., (2008) Adipocytokines and the metabolic complications of obesity. The Journal of Clinical Endocrinology and Metabolism, 93, S64-S73.
6. Mori, K., Emoto, M., Yokoyama, H., et al. (2006) Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care, 29, 468. (Pubitemid 44106548)
7. Cho, Y.M., Youn, B.S., Lee, H., et al. (2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care, 29, 2457-2461. (Pubitemid 44912252)
8. Graham, T.E., Yang, Q., Bluher, M., et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. The New England Journal of Medicine, 354, 2552-2563. (Pubitemid 43882351)
9. Tonjes, A., Fasshauer, M., Kratzsch, J., et al. (2010) Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE, 5, e13911.
10. Osei, K., Gaillard, T., &, Schuster, D., (2005) Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obesity Research, 13, 179-185.
11. Denecke, B., Graber, S., Schafer, C., et al. (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. The Biochemical Journal, 376, 135-145. (Pubitemid 37487209)
12. Srinivas, P.R., Wagner, A.S., Reddy, L.V., et al. (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Molecular Endocrinology, 7, 1445-1455.
13. Mathews, S.T., Singh, G.P., Ranalletta, M., et al. (2002) Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes, 51, 2450-2458. (Pubitemid 34827393)
14. Stefan, N., Hennige, A.M., Staiger, H., et al. (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 29, 853-857. (Pubitemid 44115306)
15. Ix, J.H., Shlipak, M.G., Brandenburg, V.M., et al. (2006) Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation, 113, 1760-1767. (Pubitemid 43958469)
16. Ishibashi, A., Ikeda, Y., Ohguro, T., et al. (2010) Serum fetuin-A is an independent marker of insulin resistance in Japanese men. Journal of Atherosclerosis and Thrombosis, 17, 925-933.
17. Weikert, C., Stefan, N., Schulze, M.B., et al. (2008) Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation, 118, 2555-2562.
18. American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care, 32 (Suppl. 1), S62-S67.
19. Saverymuttu, S.H., Joseph, A.E., &, Maxwell, J.D., (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. British Medical Journal, 292, 13-15. (Pubitemid 16175875)
20. Friedewald, W.T., Levy, R.I., &, Fredrickson, D.S., (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
22. Lin, X., Braymer, H.D., Bray, G.A., et al. (1998) Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sciences, 63, 145-153. (Pubitemid 28298668)
23. Reinehr, T., &, Roth, C.L., (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. The Journal of Clinical Endocrinology and Metabolism, 93, 4479-4485. (Pubitemid 352789550)
24. Mohan, V., Farooq, S., Deepa, M., et al. (2009) Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Research and Clinical Practice, 84, 84-91.
25. Stefan, N., Fritsche, A., Weikert, C., et al. (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes, 57, 2762-2767.
26. Kantartzis, K., Machann, J., Schick, F., et al. (2010) The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia, 53, 882-889.
27. Stefan, N., Kantartzis, K., &, Haring, H.U., (2008) Causes and metabolic consequences of Fatty liver. Endocrine Reviews, 29, 939-960.
28. Ford, E.S., Zhao, G., &, Li, C., (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. Journal of the American College of Cardiology, 55, 1310-1317.
29. Qiao, Q., Jousilahti, P., Eriksson, J., et al. (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care, 26, 2910-2914. (Pubitemid 37205567)
30. Ix, J.H., Wassel, C.L., Kanaya, A.M., et al. (2008) Fetuin-A and incident diabetes mellitus in older persons. JAMA: The Journal of the American Medical Association, 300, 182-188. (Pubitemid 351969302)
31. Mori, K., Emoto, M., Araki, T., et al. (2008) Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus. Metabolism: Clinical and Experimental, 57, 1248-1252.
32. Hennige, A.M., Staiger, H., Wicke, C., et al. (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE, 3, e1765.
33. Schwenzer, N.F., Springer, F., Schraml, C., et al. (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. Journal of Hepatology, 51, 433-445.